Skip to Content
You are currently on the new version of our website. Access the old version .

689 Results Found

  • Article
  • Open Access
1 Citations
4,222 Views
16 Pages

Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital

  • Nico Kraus,
  • Frank Erhard Uschner,
  • Magnus Moeslein,
  • Robert Schierwagen and ,
  • Wenyi Gu,
  • Maximilian Joseph Brol,
  • Eike Fürst,
  • Inga Grünewald,
  • Sophie Lotersztajn and
  • Sabine Klein
  • + 10 authors+ 5 authors

16 October 2024

Metabolic dysfunction-associated Steatohepatitis (MASH), is a prominent cause for liver cirrhosis. MASH-cirrhosis is responsible for liver complications and there is no specific treatment. To develop new therapeutic approaches, animal models are need...

(This article belongs to the Topic Animal Models of Human Disease 2.0)
  • Article
  • Open Access
1,202 Views
20 Pages

The Impact of Post-Harvest Potato Storage on (Deep-Fried) Potato Mash Properties

  • Kathleen Hooyberghs,
  • Stijn Reyniers,
  • Paula Moldenaers,
  • Ruth Cardinaels and ,
  • Kristof Brijs and
  • Jan A. Delcour
  • + 1 author+ 0 author

20 April 2026

This study investigated whether storage changes the composition of Fontane and Challenger potatoes, including their starch characteristics, and whether these changes impact the properties of (deep-fried) mashes made from these potatoes stored for up...

(This article belongs to the Section Food Engineering and Technology)
  • Review
  • Open Access
18 Citations
10,598 Views
19 Pages

Resmetirom for MASH: A Comprehensive Review of a Novel Therapeutic Frontier

  • Angad Tiwari,
  • Ashish Sharma,
  • Harendra Kumar,
  • Varnika Gupta and ,
  • Vishal Deshpande,
  • Jaya Sai Mupparaju,
  • Tanisha Mishra,
  • Hareesha Rishab Bharadwaj,
  • Dushyant Singh Dahiya and
  • Varun Jain
  • + 5 authors+ 0 author

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease linked to type 2 diabetes (T2D), obesity, and dyslipidaemia, which are all parts of the metabolic syndrome. In 2024, for non-cirrhotic MASH with mild to advanced f...

(This article belongs to the Special Issue New Insights Into Non-Alcoholic Fatty Liver Diseases)
  • Review
  • Open Access
11 Citations
4,269 Views
28 Pages

Multifaceted Interactions Between Bile Acids, Their Receptors, and MASH: From Molecular Mechanisms to Clinical Therapeutics

  • Xuan Tang,
  • Yuanjiao Zhou,
  • Li Xia,
  • Xiulian Lin and ,
  • Yao Zhu,
  • Menghan Chen,
  • Jiayao Wang and
  • Yamei Li
  • + 3 authors+ 0 author

22 July 2025

Metabolic dysfunction-associated steatohepatitis (MASH) represents a critical hepatic manifestation within the broader spectrum of metabolic syndrome. The pathogenesis of MASH is characterized by disruptions in lipid metabolism, inflammation, and fib...

(This article belongs to the Special Issue Chemical Biology in Asia—Second Edition)
  • Article
  • Open Access
1 Citations
1,943 Views
17 Pages

Sexual Dimorphism in the Initial Apoptotic Switch During MASH Progression in Mice

  • Pradeep K. Rajan,
  • Jacqueline A. Sanabria,
  • Mathew S. Schade,
  • Utibe-Abasi S. Udoh and ,
  • Alexei Gorka,
  • Sodhi Komal,
  • Sandrine V. Pierre and
  • Juan Sanabria
  • + 3 authors+ 0 author

3 February 2026

MASH is a progressive liver disease closely associated with cellular senescence, which is present in more than 80% of hepatocytes in patients who develop hepatocellular carcinoma (HCC). Although MASH affects both sexes, the incidence of MASH-related...

(This article belongs to the Special Issue The Na, K-ATPase in Health and Disease)
  • Article
  • Open Access
86 Citations
18,537 Views
16 Pages

22 October 2012

Bio-ethanol is one of the energy sources that can be produced by renewable sources. Waste potato mash was chosen as a renewable carbon source for ethanol fermentation because it is relatively inexpensive compared with other feedstock considered as fo...

(This article belongs to the Special Issue Renewable Energy)
  • Article
  • Open Access
2 Citations
2,183 Views
15 Pages

An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis

  • Feixiang Xiong,
  • Xuejie Zhang,
  • Yuyong Jiang,
  • Peipei Meng and ,
  • Yang Zhou,
  • Xiaomin Ji,
  • Jialiang Chen,
  • Tong Wu and
  • Yixin Hou
  • + 4 authors+ 0 author

4 December 2024

Background and aim: The prevalence and adverse outcomes of metabolic dysfunction associated with steatotic liver disease (MAFLD) are increasing. The changes in the gut microbiota and metabolites associated with metabolic dysfunction-associated steato...

(This article belongs to the Section Lipid Metabolism)
  • Review
  • Open Access
710 Views
24 Pages

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are a growing global health burden with extremely limited pharmacological options, thereby indicating...

(This article belongs to the Special Issue Targeted Peptide Drugs for Metabolic Diseases)
  • Article
  • Open Access
6 Citations
4,929 Views
16 Pages

Single-Cell RNA Sequencing Reveals Macrophage Dynamics During MASH in Leptin-Deficient Rats

  • Xiaoming Xin,
  • Yaohua Ni,
  • Jing Wang,
  • Fenglin Wu and ,
  • Meichen Liu,
  • Lingjuan Wu,
  • Jiaxing Dai,
  • Chenglin Wu,
  • Xiaolei Song and
  • Xianmin Zhu
  • + 8 authors+ 3 authors

10 January 2025

Macrophages play important roles in metabolic dysfunction-associated steatohepatitis (MASH), an advanced and inflammatory stage of metabolic dysfunction-associated steatotic liver disease (MASLD). In humans and mice, the cellular heterogeneity and di...

  • Review
  • Open Access
11 Citations
6,350 Views
28 Pages

29 March 2025

Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of fatty liver disease, presents a significant global health challenge. Despite extensive research, fully elucidating its complex pathogenesis and developing accurate non-inv...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
6 Citations
3,306 Views
14 Pages

Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression

  • Ana C. Maretti-Mira,
  • Matthew P. Salomon,
  • Shefali Chopra,
  • Liyun Yuan and
  • Lucy Golden-Mason

Neutrophils play a crucial role in host defense against infection. Aberrant neutrophil activation may induce tissue damage via sterile inflammation. Neutrophil accumulation has been identified as a feature of the inflammatory response observed in met...

(This article belongs to the Section Cell Biology and Pathology)
  • Review
  • Open Access
46 Citations
13,502 Views
26 Pages

Nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated steatotic liver disease (MASLD), is a liver condition that is linked to overweight, obesity, diabetes mellitus, and metabolic syndrome. Nonalcoholic steatohepatitis (NASH),...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
1 Citations
913 Views
15 Pages

18 August 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease, and its progressive inflammatory phenotype, metabolic dysfunction-associated steatohepatitis (MASH), is characterized by hepatocellular inju...

(This article belongs to the Special Issue Mechanisms and Prevention in Steatotic Liver Disease)
  • Article
  • Open Access
1 Citations
4,399 Views
24 Pages

Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH

  • Julie S. Pedersen,
  • Lili Niu,
  • Nicolai J. Wewer Albrechtsen,
  • Viggo B. Kristiansen and ,
  • Inge Marie Poulsen,
  • Reza R. Serizawa,
  • Torben Hansen,
  • Lise Lotte Gluud,
  • Sten Madsbad and
  • Flemming Bendtsen
  • + 5 authors+ 0 author

10 April 2025

Background/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this...

(This article belongs to the Special Issue Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment)
  • Article
  • Open Access
4 Citations
3,200 Views
11 Pages

Accuracy of Velacur in Assessing MASLD and MASH Patients Using Biopsy as the Gold Standard

  • Muhammad Y. Sheikh,
  • Nameer Hasan,
  • Marwan Almozuaghi,
  • Nadeem M. Akhtar and ,
  • Yugjeet Grewal and
  • Caitlin Schneider
  • + 1 author+ 0 author

Background/Objectives: VelacurTM is a novel, point-of-care ultrasound device developed to accurately diagnose patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)....

(This article belongs to the Section Point-of-Care Diagnostics and Devices)
  • Review
  • Open Access
651 Views
40 Pages

The Role of the OSM/OSMRβ Axis in Chronic Liver Disease Progression and Hepatocellular Carcinoma Development: A Focus on MASLD/MASH

  • Beatrice Foglia,
  • Jessica Nurcis,
  • Marta Signorini,
  • Erica Novo and ,
  • Claudia Bocca,
  • Stefania Cannito and
  • Maurizio Parola
  • + 2 authors+ 0 author

15 September 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the emerging leading cause of Chronic Liver Disease (CLD) worldwide, with a global prevalence of approximately 30% in the general population that parallels global rates of ob...

(This article belongs to the Special Issue Pathological Changes and Pathogenic Mechanisms of Chronic Liver Disease)
  • Article
  • Open Access
3 Citations
9,472 Views
24 Pages

INHIBITION OF THE PROSTAGLANDIN-DEGRADING ENZYME 15-PGDH AMELIORATES MASH-ASSOCIATED APOPTOSIS AND FIBROSIS IN MICE

  • Utibe-Abasi S. Udoh,
  • Mathew Steven Schade,
  • Jacqueline A. Sanabria,
  • Pradeep Kumar Rajan and ,
  • Rodrigo Aguilar,
  • Micheal Andryka,
  • Alexei Gorka,
  • Sandrine V. Pierre and
  • Juan Sanabria
  • + 4 authors+ 0 author

27 June 2025

Background. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of the world population. Progression to its inflammatory state, MASH, is associated with increasing liver fibrosis, leading to end-stage liver disease...

(This article belongs to the Special Issue Cellular Pathology: Emerging Discoveries and Perspectives in the USA)
  • Review
  • Open Access
1,241 Views
13 Pages

24 April 2026

Metabolic dysfunction-associated steatohepatitis (MASH) is a complex, multifactorial disease heavily influenced by the gut–liver axis. While enterotoxigenic Bacteroides fragilis (ETBF) and its principal virulence factor, B. fragilis toxin (BFT)...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
5 Citations
3,834 Views
20 Pages

13 March 2024

Non-alcoholic steatohepatitis (NASH, also known as MASH) is a severe form of non-alcoholic fatty liver disease (NAFLD, also known as MASLD). Emerging data indicate that the progression of the disease to MASH is higher in postmenopausal women and that...

(This article belongs to the Topic Advances in Genetics and Precision Medicine in Human Diseases)
  • Article
  • Open Access
7 Citations
1,622 Views
18 Pages

Novel Aurone Derivative Ameliorates MASH Lipid Metabolism via the AMPK-ACC-PPARα Axis

  • Sule Bai,
  • Yi Zou,
  • Wenyi Zhang,
  • Jiajia Yu and ,
  • Zhenzhen Qie,
  • Zhen Liu,
  • Peng Yu,
  • Cen Xiang and
  • Yuou Teng
  • + 4 authors+ 0 author

17 November 2025

Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated fatty liver disease (MASLD), is characterized by disrupted lipid metabolism and persistent inflammation, which can lead to cirrhosis and h...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Review
  • Open Access
1 Citations
1,904 Views
18 Pages

HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis

  • Antonio Giorgio,
  • Massimo De Luca,
  • Anna Lombardi,
  • Emanuela Ciracì and ,
  • Valeria Cosima Rollo,
  • Antonella Di Sarno,
  • Luca Montesarchio,
  • Giuseppe Stella and
  • Valentina Giorgio
  • + 4 authors+ 0 author

18 December 2025

Conventional ultrasound (US) has long been central to hepatocellular carcinoma (HCC) surveillance in cirrhotic patients, due to its low cost, wide availability, non-invasiveness, and adequate sensitivity for detecting small nodules. However, its spec...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
7 Citations
6,139 Views
16 Pages

Waste Bread as Raw Material for Ethanol Production: Effect of Mash Preparation Methods on Fermentation Efficiency

  • Maria Balcerek,
  • Urszula Dziekońska-Kubczak,
  • Katarzyna Pielech-Przybylska,
  • Anna Oleszczak and ,
  • Magdalena Koń and
  • Andrea Maria Patelski
  • + 1 author+ 0 author

20 October 2024

The issue of managing waste bread is a global concern, with significant environmental and the economic implications. The utilisation of waste bread for bioethanol production, employing energy-saving technology, could prevent these consequences and re...

(This article belongs to the Special Issue Bioprocessing and Fermentation Technology for Biomass Conversion)
  • Review
  • Open Access
14 Citations
5,977 Views
22 Pages

The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions

  • Onyinye Ugonabo,
  • Utibe-Abasi Sunday Udoh,
  • Pradeep Kumar Rajan,
  • Heather Reeves and ,
  • Christina Arcand,
  • Yuto Nakafuku,
  • Tejas Joshi,
  • Rob Finley,
  • Sandrine V. Pierre and
  • Juan Ramon Sanabria
  • + 5 authors+ 0 author

9 September 2023

Metabolic dysfunction-associated steatohepatitis (MASH) is one of the major risk factors for chronic liver disease and hepatocellular carcinoma (HCC). The incidence of MASH in Western countries continues to rise, driving HCC as the third cause of can...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
3 Citations
2,410 Views
21 Pages

The global burden of type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise at an alarming pace, with substantial pathophysiological overlap driven by insulin resistance, visceral obesit...

(This article belongs to the Section Endocrinology and Metabolism Research)
  • Systematic Review
  • Open Access
1 Citations
2,161 Views
20 Pages

30 March 2026

Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease and a major driver of cirrhosis, liver failure, and mortality worldwide. Despite the urgent need for effective therapies, clinical trials in...

(This article belongs to the Special Issue Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) and Concomitant Illnesses: Diagnostic and Therapeutic Implications)
  • Case Report
  • Open Access
1 Citations
12,088 Views
10 Pages

Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with Tirzepatide in MASH Cirrhosis

  • Thuy-Duyen Nguyen,
  • Dora Lam-Himlin,
  • Blanca Lizaola-Mayo and
  • David Chascsa

Background/Objectives: The growing prevalence of metabolic-associated steatotic liver disease (MASLD)/metabolic-associated steatohepatitis (MASH) is forecasted to be over 55% by 2040, representing a significant driver of cirrhosis and highlighting de...

(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice)
  • Article
  • Open Access
2 Citations
2,187 Views
34 Pages

UPLC-MS/MS Metabolomics Reveals Babao Dan’s Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking

  • Shijiao Zhang,
  • Yanding Su,
  • Ao Han,
  • He Qi and ,
  • Jiade Zhao and
  • Xiangjun Qiu
  • + 1 author+ 0 author

25 July 2025

Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive disease that easily develops into cirrhosis and hepatocellular carcinoma, but its pathogenesis is not clear, and most therapeutic drugs have obvious limitations. How...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
467 Views
18 Pages

Mechanism-Oriented Model Selection in MASH Research: Insights from the iHFC Diet and TSOD/TSNO Mice

  • Mayuko Ichimura-Shimizu,
  • Wenhua Shao,
  • Hirohisa Ogawa,
  • Shotaro Tachibana and
  • Koichi Tsuneyama

4 September 2026

Metabolic dysfunction-associated steatohepatitis (MASH) represents a systems-level disorder driven by the interplay of metabolic stress, bile acid dysregulation, gut microbiota remodeling, and immune activation. Because no single experimental platfor...

  • Article
  • Open Access
666 Views
18 Pages

Andrias davidianus Liver-Derived Peptides Ameliorate MASH Accompanied by Attenuation of PPARγ Signaling and Selective Modulation of Gut Microbiota

  • Xing Shen,
  • Ya-Na Qu,
  • Yi-Xiao Huang,
  • Chen-Yu Liang and ,
  • Si-Jia Liu,
  • Na Liu,
  • Zi-Jie He,
  • Shuai-Kun Su,
  • Qing-Zhu Sun and
  • Hua Han
  • + 6 authors+ 1 author

Background: Metabolic dysfunction-associated steatohepatitis (MASH), the progressive stage of metabolic dysfunction-associated steatotic liver disease (MASLD), is characterized by hepatic steatosis, inflammation, and fibrosis, yet no specific therapy...

(This article belongs to the Section Animal Metabolism)
  • Article
  • Open Access
5 Views
23 Pages

Integrative Transcriptomic Analysis Identifies AJ009632.2 as a Candidate Associated with MASLD/MASH-Related Lipid and Inflammatory Responses

  • Ebenezeri Erasto Ngowi,
  • Siyu An,
  • Jiaqi Zou,
  • Agness Phiri and ,
  • Nannan Zheng,
  • Diru Yao,
  • Yuanhang Yue,
  • Xiaodan Zhang,
  • Rui Zhou and
  • Aijun Qiao
  • + 11 authors+ 6 authors

15 November 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 16% of the global population, and its progression to steatohepatitis (MASH) increases the risk of cirrhosis and hepatocellular carcinoma. Long non-coding RNAs (lncRNAs) hav...

(This article belongs to the Section Medical Biology)
  • Article
  • Open Access
3 Citations
2,808 Views
15 Pages

Oxy210 Inhibits Hepatic Expression of Senescence-Associated, Pro-Fibrotic, and Pro-Inflammatory Genes in Mice During Development of MASH and in Hepatocytes In Vitro

  • Feng Wang,
  • Simon T. Hui,
  • Frank Stappenbeck,
  • Dorota Kaminska and ,
  • Aldons J. Lusis and
  • Farhad Parhami
  • + 1 author+ 0 author

2 August 2025

Background: Senescence, a state of permanent cell cycle arrest, is a complex cellular phenomenon closely affiliated with age-related diseases and pathological fibrosis. Cellular senescence is now recognized as a significant contributor to organ fibro...

  • Article
  • Open Access
2 Citations
1,866 Views
10 Pages

The Influence of Milling Granulation on The Proportion of Fermentable and Non-Fermentable Ingredients in Mash Obtained from Mixed Endosperm Wheat

  • Vinko Krstanović,
  • Krešimir Mastanjević,
  • Iztok Jože Košir,
  • Miroslav Jurić and
  • Kristina Habschied

9 July 2024

The use of purpose-selected wheat in brewing is limited because it is either not suitable for the application of usual agrotechnical measures or, more often, is not adapted to specific climatic conditions. As unmalted wheat in brewing can cause proce...

  • Article
  • Open Access
2 Citations
1,378 Views
10 Pages

MRI-Based Assessment of Etiology-Specific Sarcopenia Phenotypes in Chronic Liver Disease: A Comparative Study of MASH and Viral Hepatitis

  • Mika Yasutomi,
  • Kazuhiro Saito,
  • Yoichi Araki,
  • Katsutoshi Sugimoto and ,
  • Daisuke Yoshimaru,
  • Shuhei Shibukawa and
  • Masanori Ishida
  • + 2 authors+ 0 author

Background: Sarcopenia is a clinically important complication of chronic liver disease (CLD), but its underlying mechanisms may differ according to disease etiology. Quantitative MRI biomarkers, including proton density fat fraction (PDFF) and magnet...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
8 Citations
8,239 Views
11 Pages

The Long-Term Effect of Weight Loss on the Prevention of Progression to Cirrhosis among Patients with Obesity and MASH-Related F3 Liver Fibrosis

  • Jiafei Niu,
  • Wael Al-Yaman,
  • Kanokwan Pinyopornpanish,
  • Ji Seok Park and ,
  • Miguel Salazar,
  • Huijun Xiao,
  • James Bena,
  • Ruishen Lyu,
  • Gianina Flocco and
  • Jamile Wakim-Fleming
  • + 8 authors+ 3 authors

This multi-center retrospective study examined the effect of weight loss on the prevention of progression to cirrhosis in a sample exclusively composed of patients with obesity and MASH-related F3 liver fibrosis. Adult patients with obesity and biops...

(This article belongs to the Special Issue Nutrition-, Overweight- and Obesity-Related Health Issues)
  • Article
  • Open Access
3 Citations
1,888 Views
13 Pages

20 June 2025

Background: The STING (Stimulator of Interferon Genes) pathway plays a vital role in the body’s innate immune defense system, primarily involved in DNA sensing and type I interferon production. While STING is well-established in various immune...

(This article belongs to the Special Issue Inflammation in Target Organs)
  • Article
  • Open Access
1 Citations
1,869 Views
22 Pages

Performance Evaluation of a Sustainable Glulam Timber Rubrail and Noise Wall System Under MASH TL-3 Crash Conditions

  • Tewodros Y. Yosef,
  • Ronald K. Faller,
  • Qusai A. Alomari,
  • Jennifer D. Schmidt and
  • Mojtaba Atash Bahar

Noise barriers are commonly used to reduce the adverse effects of traffic noise in both urban and suburban settings. While conventional systems constructed from concrete and steel provide reliable acoustic and structural performance, they raise susta...

  • Review
  • Open Access
10 Citations
3,045 Views
29 Pages

GLP-1-based drugs are approved for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 60% of patients with T2DM, and the gut microbiome plays a critical rol...

(This article belongs to the Section Endocrinology and Metabolism Research)
  • Systematic Review
  • Open Access
21 Citations
10,126 Views
16 Pages

Introduction: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic-Dysfunction Associated Steatohepatitis (MASH) are linked to obesity, type 2 diabetes, and metabolic syndrome, increasing liver-related morbidity and cardiova...

(This article belongs to the Special Issue New Insights Into Non-Alcoholic Fatty Liver Diseases)
  • Article
  • Open Access
28 Citations
4,707 Views
16 Pages

Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver

  • Mrigya Babuta,
  • Prashanth Thevkar Nagesh,
  • Aditi Ashish Datta,
  • Victoria Remotti and ,
  • Yuan Zhuang,
  • Jeeval Mehta,
  • Francesca Lami,
  • Yanbo Wang and
  • Gyongyi Szabo
  • + 4 authors+ 0 author

1 June 2024

Binge drinking in obese patients positively correlates with accelerated liver damage and liver-related death. However, the underlying mechanism and the effect of alcohol use on the progression of metabolic-dysfunction-associated steatotic liver disea...

(This article belongs to the Special Issue Inflammation in Target Organs)
  • Article
  • Open Access
855 Views
27 Pages

5 September 2026

Metabolic dysfunction-associated steatohepatitis (MASH) progresses through macrophage activation and hepatic stellate cell (HSC)-driven fibrogenesis. As cell-level single-cell discoveries often suffer from pseudoreplication and fail to replicate acro...

(This article belongs to the Special Issue Research on System Biology Methods and Tools for Integrating Omics Data)
  • Article
  • Open Access
7 Citations
1,927 Views
34 Pages

Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats

  • Laura Giuseppina Di Pasqua,
  • Sofia Lotti,
  • Michelangelo Trucchi,
  • Giuseppina Palladini and ,
  • Anna Cleta Croce,
  • Francesca Protopapa,
  • Fausto Feletti,
  • Stefan G. Kauschke,
  • Peng Sun and
  • Andrea Ferrigno
  • + 6 authors+ 1 author

Background: Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a multifactorial liver disease in which mitochondrial dysfunction, oxidative stress, and inflammation play key roles in driving the progression toward metabolic dysfuncti...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Article
  • Open Access
856 Views
18 Pages

20 September 2026

Introduction: Animal models of cardiac dysfunction and heart failure play important roles in preclinical study and drug discovery. Cardiovascular disease and metabolic dysfunction-associated steatohepatitis (MASH) are closely associated metabolic dis...

(This article belongs to the Section Nutritional Immunology)
  • Article
  • Open Access
309 Views
18 Pages

9 October 2026

The crosstalk between the liver and the lung is complex and not yet fully understood; however, recent studies suggest that metabolic dysfunction, often originating in the liver, can influence lung injury and other lung diseases. The current study inv...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
414 Views
26 Pages

1 October 2026

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are increasingly recognized as systemic cardiometabolic disorders rather than isolated liver diseases....

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
1 Citations
514 Views
10 Pages

28 July 2026

Background/Objectives: The blood urea nitrogen-to-serum albumin ratio (BAR) is a recently established index that has been associated with systemic inflammation. This study aimed to evaluate the association between BAR levels and histopathological fin...

(This article belongs to the Special Issue Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease)
  • Review
  • Open Access
980 Views
30 Pages

From Proteomic Signatures to Candidate Endotypes in Obesity, Type 2 Diabetes, MASLD/MASH, and MetALD: Study Designs, Bioinformatics, and Biostatistical Strategies

  • Zhennan Wu,
  • Sachin Anil Ghag,
  • Md Hasan Imam Shihab,
  • Aatman Pushkarkumar Vasoya and ,
  • Vinamrata Sharma,
  • Jacob Patton Hickman,
  • Yijie Wang,
  • Xiaoqing Huang and
  • Menghao Huang
  • + 4 authors+ 0 author

20 September 2026

Obesity, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and dual-etiology metabolic dysfunction-associated alcohol-related liver disease (MetALD) form...

(This article belongs to the Section Proteomics of Human Diseases and Their Treatments)
  • Article
  • Open Access
4 Citations
5,162 Views
15 Pages

An FPGA-Based 16-Bit Continuous-Time 1-1 MASH ΔΣ TDC Employing Multirating Technique

  • Ahmad Mouri Zadeh Khaki,
  • Ebrahim Farshidi,
  • Sawal Hamid MD Ali and
  • Masuri Othman

5 November 2019

An all-digital voltage-controlled oscillator (VCO)-based second-order multi-stage noise-shaping (MASH) ΔΣ time-to-digital converter (TDC) is presented in this paper. The prototype of the proposed TDC was implemented on an Altera Stratix I...

(This article belongs to the Special Issue Low-Voltage Integrated Circuits Design and Application)
  • Article
  • Open Access
43 Citations
4,484 Views
18 Pages

Mitigation of Cadmium Induced Oxidative Stress by Using Organic Amendments to Improve the Growth and Yield of Mash Beans [Vigna mungo (L.)]

  • Muhammad Umer Chattha,
  • Warda Arif,
  • Imran Khan,
  • Walid Soufan and ,
  • Muhammad Bilal Chattha,
  • Muhammad Umair Hassan,
  • Najeeb Ullah,
  • Ayman El Sabagh and
  • Sameer H. Qari
  • + 4 authors+ 0 author

27 October 2021

Cadmium (Cd) stress is a serious environmental hazard that has devastating impacts on plant growth and productivity. Moreover, the entrance of Cd into the human food chain by eating Cd-contaminated food also poses serious health issues. Organic amend...

(This article belongs to the Section Crop Breeding and Genetics)
  • Review
  • Open Access
5 Citations
1,801 Views
48 Pages

Background/Objectives: Metabolic-dysfunction-associated steatotic liver disease (MASLD) and metabolic-dysfunction-associated steatohepatitis (MASH) arise in the setting of obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. This rev...

(This article belongs to the Special Issue Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome: 2nd Edition)
  • Article
  • Open Access
1 Citations
1,864 Views
13 Pages

7 September 2025

TB-840 is a novel RORα agonist being developed by Therasid Bioscience Inc. for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). This first-in-human study evaluated the safety, tolerability, pharmacokinetics, and food ef...

(This article belongs to the Section Pharmaceutical Science)

of 14